- 1
- 0
- 约1.29千字
- 约 39页
- 2019-06-09 发布于天津
- 举报
乳腺癌的内分泌治疗;乳癌内分泌治疗历史;乳癌内分泌治疗药物;三苯氧胺 TAM (Tamoxifen,他莫昔芬);Tamoxifen Adjuvant Therapy;Tamoxifen Adjuvant Therapy for Breast Cancer (I);Tamoxifen Adjuvant Therapy for Breast Cancer (II);Tamoxifen Adjuvant Therapy for Breast Cancer (III);Tamoxifen Adjuvant Therapy for Breast Cancer (IV);;;Generation
First
Second
Third ;高选择性芳香化酶抑制剂;Femara (Letrozole) vs Aminoglutethimide (AG);Femara AG Clinical Benefit (CR+PR+SD=6 个月) %;Femara AG Median Duration of Clinical Benefit (months);Anastrozole (Arimdex) vs Megestrol Acetate in Advanced Breast Cancer Phase III Trials;Survival DataAnastroz
原创力文档

文档评论(0)